![Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication - Kinoshita - Neuropsychopharmacology Reports - Wiley Online Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication - Kinoshita - Neuropsychopharmacology Reports - Wiley Online](https://onlinelibrary.wiley.com/cms/asset/d00555c0-c962-4b84-b65d-7ca0678c2b46/npr212342-toc-0001-m.jpg?trick=1685580747859)
Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication - Kinoshita - Neuropsychopharmacology Reports - Wiley Online
![PDF] Antipsychotic-associated weight gain: management strategies and impact on treatment adherence | Semantic Scholar PDF] Antipsychotic-associated weight gain: management strategies and impact on treatment adherence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e141c994dd44b24739e4875585af52ec24dad4d2/2-Table1-1.png)
PDF] Antipsychotic-associated weight gain: management strategies and impact on treatment adherence | Semantic Scholar
![Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/912d2fe2-ec67-413f-88c7-211d02b25dc8/gr1_lrg.jpg)
Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis - The Lancet Psychiatry
![These highlights do not include all the information needed to use ASENAPINE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for ASENAPINE SUBLINGUAL TABLETS. ASENAPINE sublingual tablets, for oral use Initial These highlights do not include all the information needed to use ASENAPINE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for ASENAPINE SUBLINGUAL TABLETS. ASENAPINE sublingual tablets, for oral use Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=asp-10.jpg&id=685178)
These highlights do not include all the information needed to use ASENAPINE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for ASENAPINE SUBLINGUAL TABLETS. ASENAPINE sublingual tablets, for oral use Initial
![PDF) Effect of asenapine and iloperidone on weight gain in patients of psychosis: a prospective study PDF) Effect of asenapine and iloperidone on weight gain in patients of psychosis: a prospective study](https://i1.rgstatic.net/publication/368338818_Effect_of_asenapine_and_iloperidone_on_weight_gain_in_patients_of_psychosis_a_prospective_study/links/63e39513e2e1515b6b7e7854/largepreview.png)